STOCK TITAN

Pzena reports 13.8% Baxter (BAX) stake in updated Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Pzena Investment Management, LLC reports beneficial ownership of 70,866,049 shares of Baxter International Inc. common stock, representing 13.8% of the class as of December 31, 2025. Pzena has sole voting power over 58,815,905 shares and sole dispositive power over the full 70,866,049 shares, with no shared voting or dispositive power.

The filing states that the securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Baxter. Pzena’s clients have the right to receive dividends and sale proceeds from these securities, but no single client has an interest in more than five percent of Baxter’s outstanding common stock.

Positive

  • None.

Negative

  • None.

Insights

Pzena reports a sizable, passive 13.8% stake in Baxter.

Pzena Investment Management, LLC discloses beneficial ownership of 70,866,049 Baxter common shares, or 13.8% of the class as of December 31, 2025. It holds sole voting power over 58,815,905 shares and sole dispositive power over the full position, indicating significant influence on how this block may be voted in routine matters.

The Schedule 13G/A is filed on a passive basis, and the certification explicitly states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control. Economic exposure resides with underlying clients, and no individual client exceeds 5% of Baxter’s shares, which disperses control among many investors.

This disclosure primarily clarifies the structure of Baxter’s shareholder base rather than signaling a strategic move. Subsequent ownership updates in later Schedule 13G or 13D filings, if any, would provide further detail on changes in Pzena’s position or intent.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



PZENA INVESTMENT MANAGEMENT LLC
Signature:s/Steven Coffey
Name/Title:Chief Legal Risk Officer & Chief Compliance Officer
Date:01/21/2026

FAQ

How many Baxter (BAX) shares does Pzena Investment Management own?

Pzena Investment Management, LLC reports beneficial ownership of 70,866,049 shares of Baxter International Inc. common stock as of December 31, 2025, according to the Schedule 13G/A.

What percentage of Baxter (BAX) does Pzena Investment Management hold?

Pzena Investment Management, LLC reports holding 13.8% of Baxter International’s outstanding common stock as of December 31, 2025.

How much voting power does Pzena have in Baxter (BAX)?

Pzena has sole voting power over 58,815,905 Baxter common shares and no shared voting power, as disclosed in the Schedule 13G/A.

Is Pzena’s Baxter (BAX) stake considered passive or activist?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Baxter, indicating a passive investment stance.

Who ultimately benefits from Pzena’s Baxter (BAX) holdings?

The filing explains that Pzena’s clients have the right to receive and direct the receipt of dividends and sale proceeds from the Baxter shares, and no single client has an interest in more than 5% of the class.

What type of reporting entity is Pzena in this Baxter (BAX) filing?

Pzena Investment Management, LLC is identified as an investment adviser ("IA") filing a Schedule 13G/A with respect to its beneficial ownership of Baxter common stock.

Baxter Intl Inc

NYSE:BAX

BAX Rankings

BAX Latest News

BAX Latest SEC Filings

BAX Stock Data

10.10B
511.74M
0.37%
102.36%
4.52%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
DEERFIELD